Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

Lantern Pharma Receives FDA Authorization To Initiate Its Phase 2 Clinical Trial, Harmonic, For LP-300 In Never Smokers With Non-Small Cell Lung Cancer

By Benzinga Newsdesk
July 14, 7:01 AM
The Harmonic™ trial is a Phase 2 multi-center study focused on never smokers with advanced non-small cell lung cancer (NSCLC) and will begin patient enrollment during Q3 2022. In a previous Phase 3

LTRN

Read More
1 minute read
  • General
  • News

Hyundai Launches IONIQ 6 Electric Sedan With Over 610 Km Range

By Shivani Kumaresan
July 14, 6:35 AM
Hyundai Motor Co (OTC:HYMTF) has launched the IONIQ 6 Electrified Streamliner, its new model in the brand’s IONIQ all-electric lineup. IONIQ…

HYMTF

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Regeneron-Sanofi’s Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years

By Vandana Singh
July 14, 6:18 AM
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA’s  (NASDAQ:SNY) Phase 3 trial of Dupixent (dupilumab) in children aged 1 to 11 years…

REGN

Read More
2 minute read
  • General
  • Media
  • News
  • Politics
  • Sports

‘Big Short’ Star Michael Burry Thinks Joe Biden Is ‘Greasing Wheels’ For Saudi Oil … Using Golf

By Shivdeep Dhaliwal
July 14, 6:10 AM
“The Big Short” fame Michael Burry on Thursday took a dig at President Joe Biden, who is touring the Middle East and is scheduled to visit Saudi Arabia this week.

GME

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

BeiGene Provides Regulatory Update On The U.S. Biologics License Application For PD-1 Inhibitor Tislelizumab In 2L ESCC

By Benzinga Newsdesk
July 14, 6:05 AM
FDA Defers Action on BLA Until Required Inspections Can Be Completed Due to COVID Travel Restrictions, Inspections Could Not Be Completed During Review Period

BGNE

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News

Novavax Secures FDA Emergency Authorization For Adjuvanted Covid-19 Vaccine

By Ragothaman Srinivasan
July 13, 5:59 PM
The U.S. Food and Drug Administration (FDA) grants emergency use authorization (EUA) to Novavax’s (NASDAQ: NVAX) lead candidate Adjuvanted (NVX-CoV2373) COVID-19 Vaccine for individuals 18 years of age and over.

NVAX

Read More
2 minute read
  • Analyst Ratings
  • Biotech
  • Emerging Markets
  • General
  • Health Care
  • Long Ideas
  • Markets
  • Mid Cap
  • News
  • Price Target
  • Trading Ideas
  • Upgrades

Why BioNTech Is Trading Higher Today Following A Stock Upgrade From SVB Securities Analyst

By Dylan Wechsler
July 13, 5:13 PM
SVB Securities, a division of SVB Financial Group (NASDAQ: SIVB), believes BioNTech SE – ADR (NASDAQ: BNTX) stock is trading below the most negative scenario for the COVID-19 vaccine mar

BNTX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers & Shakers
  • Penny Stocks

ContraFect Shares Plummet After Data Safety Monitoring Board Stops Late-Stage Aureus Bacteremia Study

By Ragothaman Srinivasan
July 13, 4:42 PM
The Data Safety Monitoring Board (DSMB) has recommended that ContraFect’s (NASDAQ: CFRX) on going DISRUPT trial be stopped because the conditional power of the study was below the pre-specified threshold for futility.

CFRX

Read More
2 minute read
  • General
  • Large Cap
  • News
  • Sports

Nike And Fanatics Team Up To Outperform Under Armour, Champion In College Apparel Sector

By Dylan Wechsler
July 13, 4:09 PM
Nike, Inc (NYSE: NKE) announced on July 13 that it is making a strategic shift in how it manufactures NCAA clothing in a new deal with Fanatics.

NKE

Read More
1 minute read
  • Biotech
  • General

Ensysce Biosciences Announces Initial Patients Dosed Of First Human Abuse Potential Study

By Bill Haddad
July 13, 4:08 PM
Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety and performance

ENSC

Posts pagination

Previous 1 … 2,331 2,332 2,333 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service